Hepb vacc 2 dose adult im
Products billed under this code include Heplisav-B.
Payment limit per 1 DOSE, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Heplisav-B.
Payment limit per 1 DOSE, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Heplisav-B | Dynavax Technologies Co | 43528-0002-05 | 5 | $941.05 |
| Heplisav-B | Dynavax Technologies Co | 43528-0003-05 | 5 | $941.05 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $188.21 | $0.00 | 1 DOSE | Hepb vacc 2 dose adult im | v1, posted September 17, 2026 |
| 3Q26 | $188.21 | +$10.655 | 1 DOSE | Hepb vacc 2 dose adult im | v1, posted September 15, 2026 |
| 2Q26 | $177.555 | $0.00 | 1 DOSE | Hepb vacc 2 dose adult im | v1, posted September 15, 2026 |
| 1Q26 | $177.555 | $0.00 | 1 DOSE | Hepb vacc 2 dose adult im | v1, posted September 15, 2026 |
| 4Q25 | $177.555 | $0.00 | 1 DOSE | Hepb vacc 2 dose adult im | v1, posted September 8, 2026 |
| 3Q25 | $177.555 | $0.00 | 1 DOSE | Hepb vacc 2 dose adult im | v1, posted March 10, 2026 |
| 2Q25 | $177.555 | +$9.257 | 1 DOSE | Hepb vacc 2 dose adult im | v1, posted March 10, 2026 |
| 1Q25 | $168.298 | $0.00 | 1 DOSE | Hepb vacc 2 dose adult im | v1, posted December 19, 2025 |
| 4Q24 | $168.298 | $0.00 | 1 DOSE | Hepb vacc 2 dose adult im | v1, posted June 11, 2025 |
| 3Q24 | $168.298 | +$8.014 | 1 DOSE | Hepb vacc 2 dose adult im | v1, posted June 11, 2025 |
| 2Q24 | $160.284 | $0.00 | 1 DOSE | Hepb vacc 2 dose adult im | v1, posted March 11, 2025 |
| 1Q24 | $160.284 | $0.00 | 1 DOSE | Hepb vacc 2 dose adult im | v1, posted December 19, 2024 |
| 4Q23 | $160.284 | $0.00 | 1 DOSE | Hepb vacc 2 dose adult im | v1, posted October 10, 2024 |
| 3Q23 | $160.284 | +$8.208 | 1 DOSE | Hepb vacc 2 dose adult im | v1, posted June 5, 2024 |
| 2Q23 | $152.076 | $0.00 | 1 DOSE | Hepb vacc 2 dose adult im | v1, posted February 23, 2024 |
| 1Q23 | $152.076 | $0.00 | 1 DOSE | Hepb vacc 2 dose adult im | v1, posted December 6, 2023 |
| 4Q22 | $152.076 | $0.00 | 1 DOSE | Hepb vacc 2 dose adult im | v1, posted June 22, 2023 |
| 3Q22 | $152.076 | +$7.866 | 1 dose | Hepb vacc 2 dose adult im | v1, posted June 9, 2023 |
| 2Q22 | $144.21 | $0.00 | 1 dose | Hepb vacc 2 dose adult im | v1, posted December 14, 2022 |
| 1Q22 | $144.21 | $0.00 | 1 dose | Hepb vacc 2 dose adult im | v1, posted June 8, 2022 |
| 4Q21 | $144.21 | $0.00 | 1 dose | Hepb vacc 2 dose adult im | v1, posted June 2, 2022 |
| 3Q21 | $144.21 | +$6.84 | 1 dose | Hepb vacc 2 dose adult im | v1, posted June 2, 2022 |
| 2Q21 | $137.37 | +$6.27 | 1 dose | Hepb vacc 2 dose adult im | v1, posted March 1, 2022 |
| 1Q21 | $131.10 | – | 1 dose | Hepb vacc 2 dose adult im | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.